Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment.

Ottestad, Anine Larsen; Huang, Mo; Emdal, Elisabeth Fritzke; Mjelle, Robin; Skarpeteig, Veronica; Dai, Hong Yan

Ottestad, Anine Larsen; Huang, Mo; Emdal, Elisabeth Fritzke; Mjelle, Robin; Skarpeteig, Veronica; Dai, Hong Yan.

Afiliación

Ottestad AL; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway.
Huang M; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, Norway.
Emdal EF; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), 7030 Trondheim, Norway.
Mjelle R; Department of Oncology, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, Norway.
Skarpeteig V; Department of Biosciences and Nutrition, Karolinska Institute, 17177 Stockholm, Sweden.
Dai HY; Department of Pathology, Clinic of Laboratory Medicine, St. Olavs Hospital, Trondheim University Hospital, 7030 Trondheim, Norway.

J Pers Med ; 13(1)2022 Dec 26.

Article en En | MEDLINE | ID: mdl-36675703

Palabras clave

comprehensive cancer panel; next-generation sequencing; personalized treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google